Column Group LLC Portfolio Holdings

Column Group LLC

  • $79.2 Million
  • Q3 2025

Column Group LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $79.2 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Oric Pharmaceuticals, Inc. with a value of $42.2M, Surrozen, Inc. with a value of $18.3M, Tenaya Therapeutics, Inc. with a value of $14.4M, Rapt Therapeutics, Inc. with a value of $4.28M, and Revolution Medicines, Inc. with a value of $2K.

Examining the 13F form we can see an increase of $13.5M in the current position value, from $65.7M to 79.2M.

Column Group LLC is based out at San Francisco, CA

Below you can find more details about Column Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $79.2 Million
Healthcare: $79.2 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$56.3M
$14.4 Million 18.17% of portfolio
9,400,290
Q3 2021 New

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $79.2 Million
  • Prior Value $65.7 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Column Group LLC Portfolio

Follow Column Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email